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z.2012.10Abstract The present investigation was designed to evaluate the effect of two oral administered
antibiotics (Rifampicin and Tetracycline) on some physiological parameters in the serum of male
albino rats. Histopathological alterations in liver and kidney were also examined. Data showed that
treatment of rats with rifampicin caused a signiﬁcant increase in the total cholesterol, triglycerides
and LDL-cholesterol levels, while HDL-cholesterol level showed a signiﬁcant decrease. Moreover,
signiﬁcant increases in serum AST, ALT, bilirubin and urea were observed. Also, the levels of the
total protein, albumin and alpha 1-globulin were signiﬁcantly decreased. No signiﬁcant changes
were recorded in the rest of the globulin fractions (alpha 2-, beta- and gamma-globulin) and albu-
min/globulin ratio (A/G) as well as creatinine level.
In the serum of tetracycline-treated rats, the triglycerides, LDL-cholesterol, AST, ALT, bilirubin,
urea, creatinine and gamma-globulin levels increased signiﬁcantly. On the other hand, HDL-
cholesterol, total protein, albumin levels and A/G ratio showed signiﬁcant decreases. No signiﬁcant
changes in the total cholesterol, alpha 2- and beta-globulin levels were detected.
Histological examination of the liver and kidney in the rifampicin-treated rats indicated that the
liver pathology includes necrosis of hepatocytes, cytoplasmic vacuolation, and distended sinusoids
with some lymphatic aggregations. In the kidney, the glomeruli increased in size, the mesangial
matrix was expanded and the renal tubules were degenerated. Histological analysis of liver samples
of tetracycline – treated rats revealed high vacuolation of the cytoplasm of hepatic cells, sinusoidal
dilation, hepatocellular necrosis and disappearance of the cell membrane in some hepatocytes. The
kidney sections of rats treated with tetracycline showed shrinkage of the glomeruli, widening of the
Bowman’s space, in addition to necrosis and vacuolation of the renal tubules.
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Antibiotics are widely used nowadays to cure many types of
diseases (Davey, 2000). Antibiotics have different courses of
administration depending upon the seriousness of the infection
and the potency of the antibiotic taken. The recovery time ofand hosting by Elsevier B.V. All rights reserved.
300 M.B. Shabana et al.an individual may range from a week to a whole month
(Wiegand et al., 2008). One of the foremost concerns in
modern medicine is antibiotic resistance. Over the last decade,
almost every kind of bacteria has become stronger and less
responsive to antibiotic treatment when it is really required
(Pearson, 2007). Although health beneﬁts of antibiotics are
often emphasized, the side effects of antibiotics are not
commonly known (Koju et al., 2005).
Rifampicin is a bactericidal antibiotic drug of the rifamycin
group. It is a semisynthetic compound derived from strepto-
myces spp that is used as a ﬁrst line drug for the treatment
of tuberculosis (TB) worldwide (Eminzade et al., 2008). Rifam-
picin produces many metabolic and morphological aberrations
in the liver due to the fact that the liver is the main detoxifying
site for these antitubercular drugs (Santhosh et al., 2007). The
effect of rifampicin on lipid peroxidation was a signiﬁcant in-
crease after 4 weeks of treatment of mice with rifampicin
(20 mg/kg) intraperitoneally (Upadhyay et al., 2007). Also,
Tasduq et al. (2007) demonstrated that, there is a signiﬁcant in-
crease in triglycerides and cholesterol levels of rats after
administration with rifampicin (250 mg/kg/day) for 30 days.
Santhosh et al. (2006) detected signiﬁcant increases in triglyc-
erides, cholesterol and free fatty acids in the serum of rats after
receiving anti-TB drugs (200 mg rifampicin + 200 mg isonia-
zid) for 30 days. Slight declines in the level of HDL-cholesterol
with concomitant rise in LDL-cholesterol level were also noted
.Pal et al. (2008) and Rana et al., 2010 showed signiﬁcant in-
creases in serum AST and ALT levels after treatment of rats
with anti-TB drugs. Elevated levels of AST and ALT were re-
corded after treatment of patients (Balamurugan et al., 2009)
and mice (Upadhyay et al., 2007) with rifampicin. The phar-
macokinetics of rifampicin in healthy volunteers and tubercu-
losis-patients was studied by Raﬁq et al. (2010), they observed
a decrease in the level of albumin in the patients, as rifampicin
binds only to albumin. Santhosh et al. (2007) and Eminzade
et al. (2008) showed a signiﬁcant decrease in total protein
and albumin levels in the serum of rats treated with anti-TB
drugs. Balamurugan et al. (2009) recorded a signiﬁcant de-
crease in the total protein in the serum of rats after treatment
with rifampicin (10 mg/kg) for 21 days. Yanardag et al. (2005)
recorded a signiﬁcant increase in the serum bilirubin, urea and
creatinine levels of patients that received antituberculous treat-
ments of isoniazid (300 mg/d), rifampicin (600 mg/d), pyrazin-
amide (2 g/d), and ethambutol (1 g/d) for 8 months. Santhosh
et al. (2007) observed a signiﬁcant increase in the serum biliru-
bin and a signiﬁcant decrease in the serum urea levels of rats
treated with isoniazid and rifampicin (200 mg each/kg bw/
day) for 30 days. Tasduq et al. (2007) recorded a signiﬁcant in-
crease in serum bilirubin and urea levels, but there were no sig-
niﬁcant changes in the levels of creatinine in the serum of rats
treated with rifampicin (250 mg/kg) for 30 days.
From a histological point of view, Scheuer et al. (1974)
found a wide range of histological changes ranging from iso-
lated steatosis (through varying degrees of portal inﬂammation
with neutrophil or mononuclear inﬁltrate) to conﬂuent necro-
sis in some patients who developed abnormal liver function
tests within 6 weeks of rifampicin therapy. Kalra et al. (2007)
reported diffuse microvesicular fatty inﬁltration with mild por-
tal triaditis in rats treated with isoniazid (50 mg/kg/day) and
rifampicin (100 mg/kg/day) for 7 days. Also, Tasduq et al.
(2005) pointed out that treatment of rats with anti-TB drugs
(250 mg/kg of rifampicin + 50 mg/kg of isoniazid + 100 mg/kg of pyrazinamide) once daily for 12 weeks caused membrane
disintegration and loss of the polyhedral structure in the liver,
in addition to the presence of other abnormalities like necrosis,
macro vesicular steatosis and inﬂammation.
Lee (1979) reported that rifampicin can cause hemolysis
and subsequently acute renal failure, it can also produce inter-
stitial nephritis (direct toxic effect) which is really part of a
pan-nephropathy. Moreover, some renal lesions were ob-
served, these lesions may be due to the formation of immune
complexes which were detected on capillary glomerular base-
ment membranes by immunoﬂuorescent and electron micro-
scopic techniques. The deterioration in renal function
typically appeared acutely, after the reintroduction of rifampi-
cin (Covic et al., 1998).
Tetracycline antibiotics are bacteriostatic agents with a
broad spectrum of antimicrobial activity. Besides their anti-
microbial activity, it has been shown that tetracyclines may
be useful in the treatment of pathological conditions in which
acute or chronic inﬂammations are involved, such as derma-
tological, periodontal, rheumatic and neurodegenerative dis-
eases (Bastos et al., 2007). Although the tetracyclines retain
important roles in both human and veterinary medicines,
the emergence of microbial resistance has limited their effec-
tiveness (Chopra and Roberts, 2001). Large doses of tetracy-
cline have been shown to induce hepatic dysfunction in rats
(Yin et al., 2006) and humans (Wruble and Cummins,
1965). This dysfunction of the liver resulted in the disturbance
of nitrogen metabolism, jaundice and other signs of hepato-
cellular damage, e.g., increase of serum transaminases
(Bo¨cker et al., 1982). It was found that the levels of the total
cholesterol, triglycerides and LDL-cholesterol in the serum of
rats were signiﬁcantly increased after treatment with 10 mg/
100 g body weight/day of tetracycline for 7 days, while a
signiﬁcant decrease in HDL-cholesterol levels was noticed
(Vijayalekshmi Amma and Leelamma, 1991). Also, Hunt
and Washington (1994) found a signiﬁcant increase in AST
and ALT levels in the serum of female patients treated with
tetracyclines for 2 months. Balashev and Polosova (1981)
studied the effect of tetracycline hydrochloride (25 mg/kg/
day for 7 and 20 days) on the levels of the total protein
and separate protein fractions such as alpha 1-, alpha 2-,
beta- and gamma-globulins in the lymph and blood serum
of rabbits. They found a signiﬁcant decrease in the lymph
and serum contents of both the total protein and the protein
fractions. Moreover, Zallen (2009) recorded signiﬁcant in-
creases in the levels of serum bilirubin and urea in mice after
treatment with tetracycline. Also, Miller and McGarity (2009)
demonstrated that patients treated with tetracycline (250 mg/
kg) four times daily for 7 days had renal failure. In addition,
they found an increase in urea and creatinine levels. Machado
et al. (2003) observed a moderate amount of vacuolation in
the convoluted tubules and Henle’s loop and foci of necrosis
in the tubular epithelium (that increased according to the
dose) in the kidney of the offspring of the tetracycline-treated
rats for 10 days.
With this background, the object of this study is to evaluate
the effect of rifampicin and tetracycline on liver and kidney
function in male albino rats. This was achieved by determina-
tion of the lipid proﬁle, total protein and its electrophoretic
pattern, albumin, creatinine, and urea in the blood of rats trea-
ted with rifampicin and tetracycline, and the histopathological
study of the liver and the kidney of the treated animals.
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The present study was carried out on white male albino rats
having body weight range of 120–160 g. After randomization
into various groups, rats were acclimatized for 14 days in the
new environment before carrying out the experiment. The
drugs were administered orally by means of gastric tubes. Rats
were administered with rifampicin (200 mg/kg body weight/
day, for 30 days) (Santhosh et al., 2007), or tetracycline
(140 mg/kg body weight/day, for 7 days) (Vijayalekshmi
Amma and Leelamma, 1991) before feeding.
Rats were divided into four groups
Group 1: Control for rifampicin treated rats. Animals
received 2 ml saline solution (the solvent of rifampicin)
orally for 30 days.
Group 2: Rats were treated with rifampicin orally in a dose
of 200 mg/kg body weight/day (dissolved in 2 ml saline
solution) for 30 days.
Group 3: Control for tetracycline treated rats. Animals
received 2 ml distilled water (solvent of tetracycline) orally
for 7 days.
Group 4: Rats in this group were treated with tetracycline
orally in a dose of 140 mg/kg body weight/day (dissolved
in 2 ml distilled water) for 7 days.
Blood collection was performed 24 h after the end of the
7th and 30th days. Animals were anesthetized with ether,
and the blood was collected from the abdominal aorta. The
blood sample was left 30 min at 37 C, and then centrifuged
at 5000g for ten minutes. The separated serum was used for
the estimation of the following physiological parameters:
1. Total cholesterol level was determined according to
Deeg and Ziegemohrm (1982).
2. Triglyceride level was determined according to Stein
and Myers (1995).
3. LDL and HDL-cholesterol levels were determined
according to Valerie (2002).
4. AST and ALT levels were determined according to
Schmidt and Schmidt (1963).
5. Serum total protein level was estimated using the Biuret
reaction (Young, 1990).
6. Albumin and creatinine levels were determined accord-
ing to Newman and Price (1999).
7. Electrophoretic separation of proteins was carried out
according to Jeppsson et al. (1979).
8. Urea level was determined according to Patton and
Crouch (1977).
Liver and kidney were removed and ﬁxed in Bouin’s ﬂuid
for 24 h. After ﬁxation, the organs were then dehydrated
through ascending grades of ethyl alcohol, and then they were
transferred to xylol. The organs were then placed in a mixture
of melted wax and xylol (1:1) for about 10 min and then
embedded in parafﬁn wax (56 C). Sections were made, stained
with Ehrlich’s hematoxylin, counter stained with eosin and
examined by the light microscope (Culling, 1974).Data were tabulated and analyzed using SPSS-15 (Statisti-
cal Package for Social Science version 15) according to Howell
(1995).
Results
Effect of rifampicin administration on the biochemical
parameters studied
Table 1 shows that administration of rifampicin to rats for
30 days caused a signiﬁcant increase in the total cholesterol,
triglycerides and LDL-cholesterol levels (mg/dl); the mean val-
ues increased by 6.0%, 27.3% and 21.0%, respectively, than
that of the control, respectively. In contrast, the level of
HDL-cholesterol in the serum of the treated animals was sig-
niﬁcantly decreased by 18.8%, as compared to that of the con-
trol group.
As shown in Table 1, the levels of AST and ALT were sig-
niﬁcantly increased in the serum of the treated rats. The mean
values increased by 218.7% and 92.7%, respectively, as com-
pared to that of the control groups.
Data also show that a signiﬁcant increase was noticed in the
levels of bilirubin and urea in the serum of the treated animals
as compared to that of the control groups. These increments
were 45.3% in bilirubin and 62.9% in urea than that of the
control. On the other hand, the mean value of serum creatinine
did not show any signiﬁcant difference in the treated group as
compared to that of the control group.
Concerning the total protein and its electrophoretic pattern
in the serum of the rifampicin-treated animals, it is clear from
the data illustrated in Fig. 1 that the mean values of total pro-
tein, albumin and alpha1-globulin were signiﬁcantly decreased
as compared to that of the control group. The rest of the pro-
tein fractions (alpha2-, beta-, gamma-globulin and globulin)
and A/G ratio in the treated animals recorded non-signiﬁcant
changes due to administration of rifampicin.
Effect of tetracycline administration on the biochemical
parameters studied
Table 2 shows that administration of tetracycline (140 mg/
kg body weight/day) to rats for 7 days caused a signiﬁcant in-
crease in the levels of triglycerides and LDL-cholesterol by
186.1% and 81.3% respectively, as compared to that of the
control group. Meanwhile a signiﬁcant decrease in the level
of HDL-cholesterol was noticed in the serum of the treated
rats. The mean value decreased by 44.6% in comparison to
that of the control group.
The levels of AST and ALT were signiﬁcantly increased in
the serum of the treated rats. The mean values increased by
322.5% and 333.5%, respectively as compared to that of the
control groups. On the other hand, treatment with tetracycline
for 7 days had no effect on the level of the total cholesterol in
the serum of the rats.
Signiﬁcant increases were also noticed in the levels of biliru-
bin, urea and creatinine in the serum of tetracycline-treated
animals as compared to that of the control group. The values
increased by 45.6%, 47.2% and 49.3% for bilirubin, urea and
creatinine, respectively when compared to that of the control
group (Table 2).
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Figure 2 Mean ± SD of the concentrations (g/dl) of total
protein and its electrophoretic fractions in serum of the rats,
7 days after treatment with tetracycline as compared to that of the
control group. Asterisk denotes a signiﬁcant difference from the
control value at P< 0.05.
Table 1 Mean ± SD of total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol, AST, ALT, bilirubin, urea, and creatinine
levels in the serum of rats, 30 days after treatment with rifampicin.
Parameter Control Treated Diﬀerence (%)
Total cholesterol (mg/dl) 177.60 ± 21.03 188.33* ± 16.78 6.0
Triglycerides (mg/dl) 205.80 ± 21.32 262.00* ± 73.27 27.3
LDL-cholesterol (mg/dl) 63.20 ± 12.32 76.50* ± 12.66 21.0
HDL-cholesterol (mg/dl) 73.24 ± 8.73 59.43* ± 13.72 18.8
AST (U/L) 69.80 ± 8.17 222.50* ± 56.49 218.7
ALT (U/L) 68.30 ± 7.89 131.67* ± 39.27 92.7
Bilirubin (mg/dl) 0.75 ± 0.20 1.09* ± 0.32 45.3
Urea (mg/dl) 22.60 ± 4.16 36.83* ± 5.78 62.9
Creatinine (mg/dl) 0.37 ± 0.11 0.43 ± 0.13 16.2
Each tabulated value is the average of six individual samples.
* Signiﬁcant difference from the control at P< 0.05.
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Figure 1 Mean ± SD of the concentrations (g/dl) of total
protein and its electrophoretic fractions in the serum of rats,
30 days after treatment with rifampicin as compared to that of the
control group. Asterisk denotes a signiﬁcant difference from the
control at P< 0.05.
302 M.B. Shabana et al.Regarding the effect of tetracycline administration on the
total protein and its electrophoretic pattern in the serum of
the treated rats, data in Fig. 2 exhibited that the mean values
of the total protein, albumin and A/G ratio were signiﬁcantly
decreased from 6.65 to 5.80, 4.04 to 2.66 and 1.53 to 0.87 g/dl,Table 2 Mean ± SD of total cholesterol, triglycerides, LDL-cho
creatinine levels in serum of the rats, 7 days after treatment with tet
Parameter Control
Total cholesterol (mg/dl) 113.33 ± 12.32
Triglycerides (mg/dl) 39.67 ± 5.28
LDL-cholesterol (mg/dl) 44.00 ± 7.62
HDL-cholesterol (mg/dl) 81.57 ± 12.84
AST (U/L) 76.17 ± 18.12
ALT (U/L) 68.17 ± 13.21
Bilirubin (mg/dl) 0.57 ± 0.38
Urea (mg/dl) 20.83 ± 4.96
Creatinine (mg/dl) 0.69 ± 0.22
Each tabulated value is the average of six individual samples.
* Signiﬁcant difference from the control at P< 0.05.respectively. On the other hand, treatment with tetracycline
caused a signiﬁcant increase in the level of the gamma-globulin
fraction in the serum of the rats. The level increased from 0.18
to 0.77 g/dl. The rest of the protein fractions (alpha 1, alpha 2,
beta-globulin and globulin) in the treated rats were not signif-
icantly changed (Fig. 2).lesterol and HDL-cholesterol, AST, ALT, bilirubin, urea, and
racycline as compared to that of the control group.
Treated Diﬀerence%
119.00 ± 13.31 4.76
113.50* ± 48.46 186.11
63.50* ± 6.06 44.31
45.17* ± 16.80 44.62
321.83* ± 46.68 322.51
295.50* ± 78.57 333.47
0.83* ± 0.31 45.61
30.67* ± 7.26 47.23
1.03* ± 0.28 49.27
Figure 4 Light micrograph of a vertical section in the liver of
albino rats after treatment with rifampicin for 30 days. Arrows
point to hypertrophied hepatocytes, vacuolated cytoplasm hepa-
tocytes (arrow heads), pycnotic nuclei (pyn), numerous kupffer
cells (K), and dilation of blood sinusoids (S). (HE) stain (X 400).
Figure 5 Light micrograph of a vertical section in the liver of
albino rats after treatment with rifampicin for 30 days. Arrows
point to hypertrophied hepatocytes, degenerated hepatocytes
(double arrows), hypertrophied kupffer cells (K), deformed nuclei
(dN) and pycnotic nuclei (pyn). (HE) stain (X1000).
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Liver
Control for rifampicin-treated rats. Fig. 3 represents a vertical
section of the liver of control for rifampicin treated rats
(2 ml saline/day for 30 days). It exhibits a normal architecture
of the hepatocytes presenting a homogenous cytoplasm and a
large spherical nucleus (N) containing one or more nucleolus
and a variable amount of dispersed and peripheral heterochro-
matin. Hepatocytes were arranged in trabecules running radi-
antly from the central vein and were separated by sinusoid (s)
containing kupffer cells (K). The lumen of sinusoid contained
mainly erythrocytes and white blood cells. Kupffer cells (K)
were found on the luminal surface of the sinusoid’s
endothelium.
Control for tetracycline-treated rats. The liver of control for
tetracycline-treated rats (2 ml distilled water for 7 days)
revealed almost the same histological picture as control for
rifampicin treated rats; it is composed of hexagonal or
pentagonal lobules with central veins and peripheral hepatic
tetrads embedded in connective tissue. Hepatocytes (arrows)
are arranged and separated by sinusoids containing kupffer
cells (K). They are regular and contain a large spheroid
nucleus with a distinctly marked nucleolus and peripheral
chromatin distribution.
Rifampicin-treated rats. The light microscopic study of the liver
of albino rats treated with 200 mg/kg body weight, daily for
30 days, shows several changes. There are dilation and conges-
tion of blood sinusoids (s) and numerous hypertrophied
kupffer cells (k) in sinusoids (Fig. 4). The liver cells were
degenerated, hypertrophy of hepatocytes which have pycnotic
nuclei (pyn) and deformed nuclei (dN) is observed (Fig. 5).
Furthermore, there is a disorganization of hepatocytes with ly-
sis of cytoplasm and some cells are completely ﬁlled with large
vacuoles (head arrows-Fig. 4) presenting a balloon like appear-
ance (Fig. 5).
Tetracycline-treated rats. The light microscopic study of the
liver of albino rats treated with 140 mg/kg body weight daily
for 7 days (Fig. 6) shows necrotic changes, a small pycnoticFigure 3 Light micrograph of a vertical section in the liver of
albino rats (the control group), showing a normal architecture
without pathological alterations. Hepatocyte (arrows), Spherical
nucleus (N), Sinusoids (S), Blood vessel (BV), and Kupffer cells
(K). (HE) stain (X400).
Figure 6 Light micrograph of a vertical section in the liver of
albino rats 7 days after tetracycline administration demonstrating
hypertrophied hepatocytes (arrows), cytoplasmic vacuolation
(arrows head), abundance of kupffer cells (K) and massive
lymphatic aggregation (LA) inside the hepatic tissue and hepato-
cellular necrosis. (HE) stain (X400).
Figure 8 Light micrograph of a transverse section of the kidney
of albino rats receiving 2 ml. distilled water/day for 7 days (control
group for tetracycline treated rats). Arrows point to distal renal
tubules (Drt) and proximal renal tubules (Prt), glomerulus (G),
glomerular capillaries (GC), erythrocytes (Er), Bowman’s capsule
(BC), and Bowman’s space (BS). (HE) stain (X400).
Figure 9 Light micrograph of a transverse section of the kidney
of albino rats after treatment with rifampicin for 30 days, it shows
glomerular swelling (GS), tightly ﬁlling the Bowman’s capsule
(BC), degeneration of distal (Drt) and proximal (Prt) renal tubules
(arrows), necrosis in the glomerulus and cellular proliferation
appear in mesengial area (M). (HE) stain (X 400).
304 M.B. Shabana et al.nucleus with condensed chromatin, lack of nucleolus and a
cytoplasm ﬁlled with vacuoles. The trabecular structure of
the lobules is slightly or distinctly blurred. Some sinusoids
are over ﬁlled with erythrocytes and the walls of most sinu-
soids show numerous kupffer cells (K). Also, aggregations of
lymphocytes (LA) inside the hepatic tissue are observed.
Kidney
Control for rifampicin-treated rats. The kidney of the control
rat has a number of nephrons. The nephron is made up of re-
nal tubules (Fig. 7 arrows) and a renal corpuscle which consists
of a cluster of capillaries (glomerulus: G) surrounded by the
Bowman’s capsule (BC). The microscopic picture of the glo-
merulus shows a capillary space covered by endothelial cells
on the inner side, which in their lumen contain nucleated blood
cells. On the inner side of the Bowman’s capsules, epithelial
cells are found. The convoluted renal tubules [distal renal tu-
bules (Drt) and proximal renal tubules (Prt)] are covered by
tall columnar cells with a weak eosinophilic cytoplasm, apical
microvilli or brush border toward the lumen as shown in
Fig. 7.
Control for tetracycline-treated rats. The kidney of control rat
of this group (2 ml. distilled water for 7 days) is composed of
normal renal glomeruli and renal tubules }distal renal tubules
(Drt) and proximal renal tubules (Prt){. The renal tubules are
lined with typical thick cubic epithelium. The tubules have a
relatively regular distinct lumen. Lobular organization of the
glomeruli and a ﬂat epithelium lining the glomerular capsule
can be seen (Fig. 8).
Rifampicin-treated rats. The light microscopic study of the kid-
ney of albino rats treated with rifampicin (200 mg/kg body
weight daily for 30 days) shows several changes (Fig. 9). The
degeneration of renal tubules [distal renal tubules (Drt) and
proximal renal tubules (Prt)] is observed in the kidney, includ-
ing lysis of cytoplasm and vacuolation (arrows). Also, the
glomerulus shows frequent shrinkage. Moreover, atrophy of
glomerular capillaries causing Bowman’s space dilation is
noticed. In addition; there are casts in some renal tubules. Cel-
lular proliferation appears in the mesengial area (M).Figure 7 Light micrograph of a transverse section of the kidney
of albino rats receiving 2 ml saline/day for 30 days (control group
for rifampicin treated rats). Arrows point to distal renal tubules
(Drt) and proximal renal tubules (Prt), glomerulus (G), glomerular
capillaries (GC), erythrocytes (Er), Bowman’s capsule (BC), and
Bowman’s space (BS). (HE) stain (X400).
Figure 10 Light micrograph of a transverse section of the kidney
of albino rats after treatment with tetracycline for 7 days. It shows
the atrophy of glomerular capillaries (GC) with Bowman’s space
dilation (BS), degeneration of distal (Drt) and proximal (Prt) renal
tubules (arrows), and some of the renal tubules contain casts (C).
(HE) stain (X400).
Figure 11 Light micrograph of a transverse section of the kidney
of albino rats after treatment with tetracycline for 7 days. Notice
the degeneration of renal glomerulus (head of arrows), adhesion of
the glomerulus (G) to Bowman’s capsule (BC), arrows indicate
degeneration of distal (Drt) and proximal (Prt) renal tubules, and
space between some renal tubules (double arrow heads). (HE)
stain (X400).
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kidney of albino rats treated with tetracycline (140 mg/kg body
weight) daily for 7 days shows similar changes in the renal tu-
bules and glomeruli as shown in rifampicin treated rats, but of
different intensity. Degeneration and necrosis of renal tubules
are evident, some tubules appear empty and have casts; C
(Fig. 10, arrows). The glomerulus shows frequent shrinkage
and complete degeneration of renal glomeruli (Fig. 11, head
of arrows). Also, some tubules show separation of the epithe-
lial cells from their membranes causing a wide space between
the renal tubules (Fig. 11, double arrow heads).
Discussion
The major disorder encountered in antitubercular drug-in-
duced hepatitis is fatty accumulation in the liver, which is
developed either due to excessive supply of lipids to the liver
or interference with lipid deposition indicating the antitubercu-
lar drug-induced hypercholesterolemic condition (Santhosh
et al., 2006). The increment of cholesterol levels in the serum
of rifampicin-administrated rats may be attributed to liver dys-
function that has been observed in the histological study as a
result of degeneration and necrosis of the hepatocytes caused
by the toxic action of rifampicin. Liver synthesizes many
important substances needed by the body, such as cholesterol
which is packaged in the cell membrane of hepatocytes as an
end product of metabolism, and then distributed to the body
to be used. So, the necrosis and damage in hepatocytes might
cause the release of the cholesterol from the hepatocytes into
the blood stream (Santhosh et al., 2006). The present study
showed that the level of LDL-cholesterol was signiﬁcantly in-
creased, whereas the level of HDL-cholesterol was signiﬁcantly
decreased in the serum of rifampicin or tetracycline treated
rats. These results are in agreement with those reported by
Santhosh et al. (2006). The abnormal cholesterol deposition
is favored by the dangerous tendency of cholesterol to passive
exchange between the plasma lipoproteins and cell membranes
(Brown and Goldstein, 1986). Also, the levels of triglycerides
were signiﬁcantly increased in the serum of animals treatedwith both drugs. Increased lipolysis of triglyceride depot liber-
ates free fatty acid from adipose tissue stores (Stenberg, 1976)
and the free fatty acids liberated by the adipose tissue are also
taken up by the liver tissue, leading to the hypertriglyceridemic
condition (Santhosh et al., 2006). However, Machado et al.
(2003) observed that the organelles which changed in the pres-
ence of tetracycline were mainly mitochondria in which, the
beta oxidation enzyme is inhibited, resulting in an accumula-
tion of triglycerides inside the cytoplasm. They stated that
hypertriglyceridemia may be due to increased release of lipo-
proteins into the circulation. Vijayalekshmi Amma and
Leelamma (1991) reported that the uptake of triglyceride rich
lipoprotein from the circulation is also decreased which is evi-
dent from the decreased activity of lipoprotein lipase of the
extrahepatic tissue. They stated that high density lipoproteins
are believed to be involved in the transport of cholesterol from
the tissue to the liver for its catabolism.
Amino transferases are important classes of enzymes link-
ing carbohydrate and amino acid metabolism. Alanine trans-
aminase (ALT) and aspartate transaminase (AST) are well
known diagnostic indicators of liver diseases. Farrell (1995) re-
ported that in cases of liver damage with hepatocellular lesions
and parenchymal cell necrosis, these marker enzymes are re-
leased from the damaged tissues into the blood stream. The
signiﬁcant elevation in the levels of ALT and AST in the serum
of rifampicin or tetracycline-administrated rats in the present
study is in accordance with the results of Kikkawa et al.
(2006) and Santhosh et al. (2006). Elevated levels of these en-
zymes in the serum are presumptive markers of drug-induced
necrotic lesions in the hepatocytes (Amr and Alaa, 2005).
The enhanced susceptibility of hepatocyte cell membrane to
drug induced peroxidative damage might have resulted in an
increased release of these diagnostic marker enzymes into the
systemic circulation. An increase in the AST and ALT levels
indicates a reversible change of the cell membrane permeability
(Bo¨cker et al., 1982). Also, the activities of these enzymes were
signiﬁcantly lower in the liver tissue of the anti-TB drugs
administrated rats (Santhosh et al., 2007).
The decrease in the total protein and albumin recorded in
the present study agrees with the results reported by Santhosh
et al., 2007; Eminzade et al. (2008), Balamurugan et al. (2009)
and Raﬁq et al. (2010). The reduction of total protein and
albumin levels indicates that the administration of drugs has
caused an impairment of liver function, e.g. its capacity to syn-
thesize albumin from the hepatic parenchyma. Khan et al.
(2002) reported that there was a differential binding of tetracy-
clines with serum albumin, while Shen et al. (2009) observed
that albumin secretion of gel entrapped hepatocytes was re-
duced by tetracycline. The decrement of alpha 1-globulin in
the serum of rifampicin-administrated rats could be due to li-
ver dysfunction which affects the synthesis of alpha protein
fractions in the liver. The increment of gamma-globulin level
in the serum of tetracycline-treated rats may be due to hyper-
plasia of the reticulo-plasmic tissue of the bone marrow in-
duced by tetracycline administration (Mikaelian, 1975).
The elevation in the serum bilirubin which was observed in
rifampicin or tetracycline-treated rats is in agreement with the
data reported by Tasduq et al. (2005) and Santhosh et al.
(2007). Hepatotoxicity is a common adverse effect of these
drugs which induce liver damage as judged by elevated serum
bilirubin (Eminzade et al., 2008; Pal et al., 2008 and Marzouk
et al., 2009).
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blood through the kidney by blood ﬁltration process. The sig-
niﬁcant increase in the level of urea in the serum of rifampicin
and tetracycline-treated rats as well as the increase in creati-
nine in the tetracycline-treated rats is in harmony with the re-
sults of earlier studies (Yanardag et al., 2005; Tasduq et al.,
2007 and Miller and McGarity, 2009). The non-signiﬁcant
changes in the level of serum creatinine of rifampicin -treated
rats could be interpreted by the fact that the level of serum cre-
atinine does not rise until at least half of the kidney’s nephrons
are destroyed or damaged (Bhattacharya et al., 2005). It has
been reported that the adverse effects of rifampicin occasion-
ally include nephritis and hepatitis (Plumb, 1999). Several iso-
lated cases of acute renal failure (ARF) following rifampicin
therapy have been reported (Yanardag et al., 2005) Tetracy-
cline has been shown to induce various forms of nephrotoxi-
city (Bihorac et al., 1999 and Zallen, 2009). The increment in
urea and creatinine levels may be attributed to the impaired re-
nal function which has been shown in the present histological
study as a result of the degeneration and necrosis in the glome-
ruli and renal tubules due to the toxic action of antibiotics on
the kidney. This action may have prevented the ﬁltration of the
waste products (urea and creatinine) from the blood stream
(Bihorac et al., 1999).
The results of the histopathological examination reﬂect the
toxicity of rifampicin to the liver and show a remarkable dam-
age of the architecture of the liver cells. These results are in
agreement with those of Awodele et al. (2010) who showed that
rifampicin induces hepatic damage. The present detected necro-
sis of the hepatic cells of rats treated with rifampicin may be
attributed to the formation of free radicals, which act as a stim-
ulator of lipid peroxidation and a source for destruction and
damage of the cell membrane (Ravi et al., 2010). Also, the cur-
rent study indicated portal triaditis and an increase in the num-
ber of kupffer cells. This is in accordance with the results of
Ravi et al. (2010) who found necrosis with moderate to heavy
portal triaditis after treatment with anti-TB drugs (Rifampicin
and Isoniazid). Cytoplasmic vacuolation of hepatocytes was
observed in the present study. Tasduq et al. (2005) suggested
that the vacuolation of hepatocytes accompanied by cytoplas-
mic rarefaction results in the loss of polyhedral structure in
the liver of rats treated with rifampicin.
The present data showed that hepatocytes in the liver of
tetracycline treated rats exhibited intense diffuse vacuolization
with many small and medium vacuoles. These data agree with
the ﬁndings of Machado et al. (2003). In the study of
Hagel-Lewicka et al. (1980), animals treated for a long period
with tetracycline presented a single large fatty vacuole in the
hepatocytes and more quantity of collagen ﬁber in the portal
spaces, probably due to the continuity of the treatment.
Amacher and Martin (1997) used single doses of tetracycline
in their experiments and likewise noted the presence of cyto-
plasmic changes such as the formation of fatty vesicles in the
hepatocytes after a few hours of administration, suggesting
metabolic changes with accumulation of triglycerides and lipid
inclusions after the use of tetracyclines. Kikkawa et al. (2006)
also showed fatty changes and focal inﬂammatory cell
inﬁltration in the liver after treatment with tetracycline. The
overall net effects on the expression of lipid metabolism genes
indicated an increase in cholesterol and triglyceride
biosynthesis and a decrease in b-oxidation of fatty acids (Yin
et al., 2006).The kidney provides the ﬁnal common pathway for the
excretion of many drugs and their metabolites, and therefore
is frequently subjected to high concentrations of potentially
toxic substances. Drugs and their metabolites are taken up
selectively and concentrated by the renal tubular cells before
excretion into the urine. So, high intracellular concentrations
are attained, particularly in the renal medulla, which has rela-
tively little vasculature compared with the cortex (Aronson,
2003). The present histological ﬁndings showed glomerular
distortion or shrinkage. Some tubular cells showed hyaline-
droplet formation and tubular dilation. Warner (1975) found
similar results. Also, Boulton-Jones et al. (1974) showed diffuse
mesengial proliferative glomerulonephritis in the renal biopsy
of patients using rifampicin with subacute infective endocardi-
tis, while Salih et al. (2008) observed interstitial nephritis and/
or acute tubular necrosis after treatment with rifampicin.
The mechanism of renal injury is thought to be due to an
allergic reaction to rifampicin or one of its metabolites causing
allergic interstitial nephritis. However, the renal biopsy does
not always show heavy inﬁltration of mononuclear cells and
occasionally the picture is that of severe, diffuse or focal tubu-
lar necrosis with mild interstitial changes (Grunfeld et al.,
1993). The immune complexes get deposited in the blood ves-
sels or interstitium and cause glomerular endotheliosis leading
to tubular injury thereby decreasing renal function (Muthuku-
mar et al., 2002). This may be possibly, the cause of renal fail-
ure in our study. Likewise, tetracycline has been shown to
induce various forms of nephrotoxicity. The current work
showed degeneration of renal glomeruli, tubules and irregular
cytoplasmic vacuolization. The same results were observed by
Mavromatis (1965). The kidney of rat’s offspring showed
slight tubular vacuolation and necrosis, more prominent in
the newborn, as well as signs of tubular regeneration on the
tenth and twentieth days from treatment with tetracycline
(Machado et al., 2003). The results of Chambers (2001) con-
cluded that the main mode of elimination of most tetracycline
is via renal glomerular ﬁltration, and it is also eliminated via
the biliary route. Approximately 60% of tetracycline adminis-
tered is found in the urine in an unchanged form.
Recommendations
– Over consumption of antibiotics may nullify their beneﬁts
and instead, lead to side effects. So, people do not tend to
consume them carelessly and without medical advice.
– All patients receiving antibiotics should have their liver and
kidney function tests periodically assessed.
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